Oncogenic KRAS modulates mitochondrial metabolism in human colon cancer cells by inducing HIF-1α and HIF-2α target genes

BACKGROUND: Activating KRAS mutations are important for cancer initiation and progression; and have recently been shown to cause primary resistance to therapies targeting the epidermal growth factor receptor. Therefore, strategies are currently in development to overcome treatment resistance due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chun, Sang Y, Johnson, Craig, Washburn, Joseph G, Cruz-Correa, Marcia R, Dang, Duyen T, Dang, Long H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999617/
https://www.ncbi.nlm.nih.gov/pubmed/21073737
http://dx.doi.org/10.1186/1476-4598-9-293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999617/
https://www.ncbi.nlm.nih.gov/pubmed/21073737
http://dx.doi.org/10.1186/1476-4598-9-293

Ejemplares similares